{"title": "The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China.", "doi": "10.1101/2020.03.09.20032045", "citation_id": "2020.03.09.20032045v1", "date": "2020-03-12", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.09.20032045", "abstract": "<p>Australia implemented a travel ban on China on February 1st 2020. Partial lifting of the ban is being considered, given the decline in incidence of COVID-19 in China. We modelled three scenarios to test the impact of travel bans on epidemic control in Australia. Scenario one was no ban, scenario two was the current ban, scenario three was a partial lifting of the current ban to allow over 100,000 university students to enter Australia, but not tourists. We used disease incidence data from China and air travel passenger movements between China and Australia, derived from incoming passenger arrival cards.  We estimated the true incidence of disease in China using data on expected proportion of under-ascertainment of cases.  We used an age specific deterministic model divided in 18 age stratified groups to model the epidemic in each scenario. The modelled epidemic with the full ban fitted the observed incidence of cases well. The modelled epidemic of the current ban predicts 57 cases on March 6th in Australia, compared to 66 observed on this date.  The modelled impact without a travel ban implemented on February the 1st shows the epidemic would continue for more than a year resulting in more than 2000 cases and about 400 deaths.   The impact of a partial lifting of a ban is minimal, and may be safe to consider.  Travel restrictions were highly effective for containing the COVID-19 epidemic in Australia and averted a much larger epidemic. The epidemic is still containable if other measures are used in tandem as cases surge in other countries. This research can inform decisions on placing or lifting travel bans as a control measure for the COVID-19 epidemic.</p>", "twitter_description": "Australia implemented a travel ban on China on February 1st 2020. Partial lifting of the ban is being considered, given the decline in incidence of COVID-19 in China. We modelled three scenarios to test the impact of travel bans on epidemic control in Australia. Scenario one was no ban, scenario two was the current ban, scenario three was a partial lifting of the current ban to allow over 100,000 university students to enter Australia, but not tourists. We used disease incidence data from China and air travel passenger movements between China and Australia, derived from incoming passenger arrival cards. We estimated the true incidence of disease in China using data on expected proportion of under-ascertainment of cases. We used an age specific deterministic model divided in 18 age stratified groups to model the epidemic in each scenario. The modelled epidemic with the full ban fitted the observed incidence of cases well. The modelled epidemic of the current ban predicts 57 cases on March 6th in Australia, compared to 66 observed on this date. The modelled impact without a travel ban implemented on February the 1st shows the epidemic would continue for more than a year resulting in more than 2000 cases and about 400 deaths. The impact of a partial lifting of a ban is minimal, and may be safe to consider. Travel restrictions were highly effective for containing the COVID-19 epidemic in Australia and averted a much larger epidemic. The epidemic is still containable if other measures are used in tandem as cases surge in other countries. This research can inform decisions on placing or lifting travel bans as a control measure for the COVID-19 epidemic.\n\n### Competing Interest Statement\n\nThe authors are employees of a university, and one of the scenarios modelled examines travel bans affecting university students.\n\n### Funding Statement\n\nThe work is supported by a National Health and Medical Research Council Centre for Research Excellence, and author CRM is supported by a National Health and Medical Research Council Principal Research Fellowship.\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nData are available and will be added as supplementary material in a peer-reviewed publication.\n\n<https://www.who.int/docs/default-source/coronaviruse/situation-reports/>", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20032045v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20032045v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20032045v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/12/2020.03.09.20032045.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.09.20032045v1", "access_rights": "restricted", "authors": ["Valentina Costantino", "David James Heslop", "Chandini Raina MacIntyre"]}